ATE310820T1 - Polymorphismus im gen für die menschliche gaba a rezeptor alpha 6 untereinheit - Google Patents

Polymorphismus im gen für die menschliche gaba a rezeptor alpha 6 untereinheit

Info

Publication number
ATE310820T1
ATE310820T1 AT00913524T AT00913524T ATE310820T1 AT E310820 T1 ATE310820 T1 AT E310820T1 AT 00913524 T AT00913524 T AT 00913524T AT 00913524 T AT00913524 T AT 00913524T AT E310820 T1 ATE310820 T1 AT E310820T1
Authority
AT
Austria
Prior art keywords
polymorphism
receptor alpha
subunit gene
human gaba
alpha
Prior art date
Application number
AT00913524T
Other languages
English (en)
Inventor
David Goldman
Nakao Iwata
Mark Shuckit
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE310820T1 publication Critical patent/ATE310820T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00913524T 1999-02-19 2000-02-18 Polymorphismus im gen für die menschliche gaba a rezeptor alpha 6 untereinheit ATE310820T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12081299P 1999-02-19 1999-02-19
PCT/US2000/004189 WO2000049151A2 (en) 1999-02-19 2000-02-18 POLYMORPHIC HUMAN GABAA RECEPTOR α-6 SUBUNIT

Publications (1)

Publication Number Publication Date
ATE310820T1 true ATE310820T1 (de) 2005-12-15

Family

ID=22392703

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00913524T ATE310820T1 (de) 1999-02-19 2000-02-18 Polymorphismus im gen für die menschliche gaba a rezeptor alpha 6 untereinheit

Country Status (6)

Country Link
EP (1) EP1153130B1 (de)
AT (1) ATE310820T1 (de)
AU (1) AU3495900A (de)
DE (1) DE60024231T2 (de)
ES (1) ES2254157T3 (de)
WO (1) WO2000049151A2 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0856581B1 (de) * 1992-12-10 2005-11-30 MERCK SHARP & DOHME LTD. Stabil transfizierte Zelllinien welche Gaba-A- Rezeptoren mit der Untereinheitenzusammensetzung alpha-3, beta-3 und gamma-2 exprimieren
US5922731A (en) * 1997-06-30 1999-07-13 Ortho Pharmaceutical Corporation 5- (heteroaryl)alkyl!-3-oxo-pyrido 1,2-a!benzimidazole-4-carboxamide derivatives useful in treating central nervous system disorders

Also Published As

Publication number Publication date
WO2000049151A3 (en) 2000-12-07
EP1153130B1 (de) 2005-11-23
AU3495900A (en) 2000-09-04
WO2000049151A2 (en) 2000-08-24
ES2254157T3 (es) 2006-06-16
DE60024231D1 (de) 2005-12-29
EP1153130A2 (de) 2001-11-14
DE60024231T2 (de) 2006-08-03

Similar Documents

Publication Publication Date Title
HUP0401591A2 (hu) Új receptor-nukleinsavak és- polipeptidek
ATE428785T1 (de) Aktive und inactive cc-chemokinrezeptoren und nukleinsäuremoleküle, die für diesen rezeptor kodieren
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
MXPA06003474A (es) Agonistas de receptores de melanocortina.
PT638172E (pt) Metodos e composicoes para monitorizacao do processamento celular da proteina precursora beta-amiloide
EP1801206A4 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
MX343744B (es) Antigenos de neisseria meningitidis y composiciones que los contienen.
TN2009000313A1 (en) Glucagon/glp - 1 receptor co-agonists
HK1062923A1 (en) Igf-binding protein-derived peptide
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
TR200103339T2 (tr) Geliştirilmiş çözülürlük özelliklerine sahip yeni LHRH-antagonistleri.
ATE551357T1 (de) Markerpeptid für die alzheimer-krankheit
MXPA03000901A (es) Peptidos presentados por las celulas.
PE20010516A1 (es) Peptidos ciclicos con afinidad mejorada por los receptores de somatostatina
ATE310820T1 (de) Polymorphismus im gen für die menschliche gaba a rezeptor alpha 6 untereinheit
Brennan et al. Stylopeptide 2, a proline-rich cyclodecapeptide from the sponge Stylotella sp.
ATE410448T1 (de) Neues peptid und pharmazeutische zusammensetzung, die dieses peptid enthält
TW200505943A (en) Polypeptide
DK1095143T3 (da) Inhibitor til diagnosticering og behandling af patienter med hæmofili A
DK0548177T3 (da) 5-Aminosalicylsyrederivater til terapi af kroniske inflammatoriske tarmsygdomme
MY150639A (en) T cell adhesion molecule and antibody thereto
BR0215265A (pt) Fludara oral com formulação de alta pureza com liberação rápida do ingrediente ativo
AU2000265052A1 (en) Somatostatin analogs for the treatment of cancer
GEP20084464B (en) Mutated neublastin
DE602004019141D1 (de) Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonin (ivtntt) enthaltende biologisch wirksame peptide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties